These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1957964)

  • 21. [The drug resistance of pathogenic bacteria of nosocomial infections in surgical intensive care unit].
    Chen J; Li LF; Guan XD; Chen DM; Chen MY; Ouyang B; Huang SW; Wu JF
    Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(17):1189-92. PubMed ID: 17147864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current orientation of antibiotic treatment in neonatal bacterial infection].
    Bégué P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):712-20. PubMed ID: 1819421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of the epidemiological situation and the resistance phenotype of pathogens isolated from patients in the intensive care unite of the Lodz Medical University Hospital No.1 in 2002-2006].
    Bartoszko-Tyczkowska A; Gaszyński W; Tyczkowska-Sieroń E
    Med Dosw Mikrobiol; 2008; 60(3):223-30. PubMed ID: 19143176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nosocomial infections in pediatric and neonatal intensive care: an epidemiological update].
    Fanos V; Cataldi L
    Pediatr Med Chir; 2002; 24(1):13-20. PubMed ID: 11938677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nosocomial bacterial infections in Intensive Care Units. I: Organisms and mechanisms of antibiotic resistance.
    Lim SM; Webb SA
    Anaesthesia; 2005 Sep; 60(9):887-902. PubMed ID: 16115251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic use and antibiotic resistance in the intensive care unit: are we curing or creating disease?
    Kollef MH
    Heart Lung; 1994; 23(5):363-7. PubMed ID: 7989204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance phenotypes circulating in nosocomial high risk departments].
    Licker M; Moldovan R; Bădiţoiu L; Negru CO; Berceanu-Văduva D; Crăciunescu M; Muntean D; Hogea E; Branea D; Dan L; Săndesc D
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):173-8. PubMed ID: 15085608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty.
    Garvin KL; Hinrichs SH; Urban JA
    Clin Orthop Relat Res; 1999 Dec; (369):110-23. PubMed ID: 10611866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibioticotherapy based on statistics in intensive therapy].
    Nardi G; Bartaletti R; De Monte A; Bertolissi M; Giordano F; Muzzi R; Sauli M; Pitzus E; Proietti A; Crucil C
    Minerva Anestesiol; 1989; 55(7-8):307-11. PubMed ID: 2622543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia.
    Combes A; Luyt CE; Trouillet JL
    Semin Respir Crit Care Med; 2006 Feb; 27(1):23-8. PubMed ID: 16508878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and epidemiological repercussions of bacterial resistance].
    Fortunio G; Cortronei G
    Minerva Med; 1975 Apr; 66(32):1519-30. PubMed ID: 1143690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibacterial chemotherapy in the surgical intensive care unit].
    Peters G
    Klin Wochenschr; 1991; 69 Suppl 26():47-52. PubMed ID: 1813730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antimicrobial chemotherapy of infection in intensive care conditions].
    Engelmann L; Lehmann D
    Z Gesamte Inn Med; 1992 Sep; 47(9):409-16. PubMed ID: 1441669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The German Society of Orthopedics and Traumatology study: pathogen spectrum and resistance status].
    Nowak ME; Härle A
    Z Orthop Ihre Grenzgeb; 1989; 127(4):484-7. PubMed ID: 2683454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotics do more than cause resistance].
    Bonten MJ
    Ned Tijdschr Geneeskd; 2011; 155(46):A4124. PubMed ID: 22108462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.